RADIANT Clinical Study

HLT, Inc. is sponsoring the RADIANT clinical study for patients with severe aortic stenosis. This study evaluates an investigational Transcatheter Aortic Valve Replacement (TAVR) procedure. The purpose of the study is to evaluate safety and performance of the Meridian II Valve in patients with severe aortic stenosis who are at intermediate or high surgical risk.
To find out more about this clinical trial or to find out if you qualify, go to www.clinicaltrials.gov